Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 1.
Figure 1.

Gain and loss of colistin resistance in A. baumannii. (A–D) The colistin minimal inhibitory concentrations (MICs) of A. baumannii isolates from the four study patients are shown. The x-axis represents time, with the shaded box indicating the time period during which the patient received colistin. The y-axis shows the colistin MICs, with the horizontal line drawn at an MIC value of 4, which is the clinical cutoff for colistin resistance. Patients' isolates include their initial susceptible isolate (S), at least one resistant isolate (R), and a post-colistin susceptible isolate (S′). (E) Models illustrating the potential evolutionary paths underlying the loss of colistin resistance in patients 1 through 4.

This Article

  1. Genome Res. 23: 1155-1162

Preprint Server